To investigate whether FATS deficiency in situ leads to enhanced T cell-mediated antitumor activity within the TME, CD4+ and CD8+ T cell phenotypes were examined in tumor-bearing WT and Fats−/− mice. The gene discussed is CD8A; the disease is neoplasm.